Vanguard Group’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $79.1M | Buy |
|
|||||
|
2025
Q2 | $47.1M | Buy |
|
|||||
|
2025
Q1 | $59.8M | Sell |
|
|||||
|
2024
Q4 | $64.5M | Sell |
|
|||||
|
2024
Q3 | $94.1M | Buy |
|
|||||
|
2024
Q2 | $98.5M | Sell |
|
|||||
|
2024
Q1 | $117M | Buy |
|
|||||
|
2023
Q4 | $93.7M | Buy |
|
|||||
|
2023
Q3 | $52.5M | Buy |
|
|||||
|
2023
Q2 | $75M | Buy |
|
|||||
|
2023
Q1 | $73.9M | Buy |
|
|||||
|
2022
Q4 | $85.6M | Buy |
|
|||||
|
2022
Q3 | $67.3M | Buy |
|
|||||
|
2022
Q2 | $53.5M | Buy |
|
|||||
|
2022
Q1 | $42.3M | Buy |
|
|||||
|
2021
Q4 | $51.2M | Buy |
|
|||||
|
2021
Q3 | $41.5M | Buy |
|
|||||
|
2021
Q2 | $36.2M | Buy |
|
|||||
|
2021
Q1 | $46.3M | Buy |
|
|||||
|
2020
Q4 | $41.2M | Buy |
|
|||||
|
2020
Q3 | $20.6M | Sell |
|
|||||
|
2020
Q2 | $21.2M | Buy |
|
|||||
|
2020
Q1 | $11.8M | Buy |
|
|||||
|
2019
Q4 | $9.39M | Sell |
|
|||||
|
2019
Q3 | $8.01M | Buy |
|
|||||
|
2019
Q2 | $9.58M | Buy |
|
|||||
|
2019
Q1 | $4.98M | Buy |
|
|||||
|
2018
Q4 | $3.78M | Buy |
|
|||||
|
2018
Q3 | $5.95M | Sell |
|
|||||
|
2018
Q2 | $5.36M | Buy |
|
|||||
|
2018
Q1 | $10.6M | Buy |
|
|||||
|
2017
Q4 | $6.05M | Buy |
|
|||||
|
2017
Q3 | $7.06M | Buy |
|
|||||
|
2017
Q2 | $7.16M | Buy |
|
|||||
|
2017
Q1 | $5.62M | Buy |
|
|||||
|
2016
Q4 | $2.8M | Buy |
|
|||||
|
2016
Q3 | $4.44M | Buy |
|
|||||
|
2016
Q2 | $1.67M | Buy |
|